Integra Lifesciences Holdings Corp
IART
Market Cap$1.18B
Close$
$25.47
59.3% upside
Current Fair Value
59.3% upsideUndervalued by 59.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.18 Billion |
|---|---|
| Enterprise Value | $960.88 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.09 |
| Beta | 1.17 |
| Outstanding Shares | 76,463,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.31 |
|---|---|
| PEG | -0.06 |
| Price to Sales | 0.76 |
| Price to Book Ratio | 1.23 |
| Enterprise Value to Revenue | 0.59 |
| Enterprise Value to EBIT | -18.73 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Integra Lifesciences Holdings Corp
CEO: Peter Arduini